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ABSTRACT
Background: Opioids have long been considered the “gold standard” of pain management;
however, the significant side effects associated with opioid use make opioid-sparing analgesic
methods appealing for various reasons. Reducing postoperative opioid consumption without
compromising pain management is an area requiring further exploration.
Objective: This study seeks to assess healthcare providers’ knowledge and confidence regarding
the use of various preoperative and perioperative interventions aimed at reducing postoperative
opioid consumption following non-emergent open abdominal surgeries. Based on the systematic
review performed, Certified Registered Nurse Anesthetists were presented with a pre-assessment
test, an educational video presentation, and a post-assessment test.
Data Sources: Investigator used Pubmed, CINAHL, and EMBASE databases to answer the
PICO (i.e., population, intervention, comparison, outcome) question: In patients undergoing
open, nonemergent abdominal surgeries, does the use of multimodal, opioid-sparing pain
management techniques during the preoperative and perioperative period reduce postoperative
opioid consumption versus non-multimodal pain management? This question became the basis
for the educational module by the same name. Pre-assessment and post-assessment testing were
used to measure the effects of the intervention. Statistical analysis was applied to assess the
effectiveness of the educational intervention.
Study Selection: Nine articles were included in the systematic review and the findings were
incorporated into the educational presentation. All found that their respective non-opioid
interventions reduced postoperative opioid consumption to some degree. A majority reported
secondary outcomes of reduced opioid-related side effects such as nausea and vomiting,
decreased time to first meal, first ambulation, and foley removal, and increased patient
satisfaction.
Results: There were nine participants in the study and survey. The pre- and post-test gauged
participants’ knowledge and confidence in non-opioid analgesic methods and implementing them
in practice. The average number of correct answers in the pre-test was 4.22, compared to 7.44 in
the post-test. Confidence for preoperative and intra-operative interventions improved from
44.44% and 33.33% to 88.89% and 100%, respectively. With education, participants were more
likely to advocate for opioid-sparing analgesic interventions to improve postoperative outcomes
for patients undergoing non-emergent abdominal surgery. All participants selected more correct
answers in the post-test than pre-test.
Conclusions: The evidence shows that several non-opioid analgesic interventions can reduce
postoperative opioid consumption. The implementation of an educational module based on these
findings led to a significant increase in providers’ knowledge and confidence of opioid-sparing
analgesic methods in patients undergoing non-emergent open abdominal surgery and the benefits
associated with non-opioid interventions.
Keywords: abdominal, abdomen, surgery, surgical, opioid-sparing, opioid, enhanced recovery
after surgery, protocol, ERAS
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INTRODUCTION
Problem Identification and Background
One of the most commonly cited fears of patients scheduled for surgery is the fear of
postoperative pain.1 A study on causes of preoperative anxiety before elective surgery found that
78% of participants were concerned about postoperative pain.2 Responsibilities of a Certified
Registered Nurse Anesthetist (CRNA) include implementing acute and chronic pain management
modalities throughout the perioperative period.3 In order to effectively utilize the various
analgesic medications available and reduce postoperative pain, the CRNA must have an in-depth
understanding of pharmacology, pain pathways, and medication side effects.
Opioids have long been considered the “gold standard” of pain management primarily
due to their mechanism of action on presynaptic opioid receptors located throughout the body.4
Despite their proven efficacy in pain management, the side effects of opioids are significant and
include bradycardia, hypothermia, urinary retention, constipation, physical dependence, and
respiratory depression.4 Furthermore, an emerging number of studies show a unique phenomenon
of opioid-induced hyperalgesia that may lead to increased morbidity, mortality, length of
hospitalization, and chronic pain development.5
Over recent decades, the rising risk of opioid abuse, dependence, addiction, and overdose
deaths has become increasingly substantial.6 Beginning in the 1990s, misinformation regarding
the addictive properties of opioids was spread by pharmaceutical companies, leading to increased
opioid prescriptions by healthcare providers.7 As diversion and misuse of opioid pain medication
escalated, the rates of opioid overdose climbed as well. In 2017, the U.S. Government declared
the opioid epidemic a public health emergency, and as a result, opioid prescription and
dependence gained heightened attention in the healthcare field.8
The incidence of opioid abuse postoperatively varies based on several non-modifiable
factors, including age, genetics, medical history, and surgical procedure.7 Simply undergoing
surgery is a risk factor for persistent and chronic opioid use postoperatively.9 However, an

6
evidence-based, multimodal pain management approach is not only modifiable, but also within
the CRNA’s scope of practice to implement in appropriate patient populations. A balanced
anesthetic plan is associated with improved patient outcomes, shorter inpatient stays, and reduced
rate of complications.5
Beyond the side effects and risks associated with prolonged postoperative opioid use,
one must also consider the complications associated with inadequate pain control. Ineffectively
controlled postoperative pain is related to increased morbidity, decreased functional capabilities,
prolonged recuperation time, extended periods of narcotic use, and higher medical services
costs.10 Therefore, aiming to reduce opioid consumption postoperatively requires a solution more
comprehensive than simply withholding opioids from surgical patients. A multimodal, opioidsparing pain management regimen must balance the risks of opioid overuse with the risks of
inadequate pain management to reduce the negative impacts of each and provide patients with
desirable outcomes.
Problem Significance
A multimodal pain management regimen aims to limit opioid use and the associated side
effects, including dependence and addiction, without compromising pain management quality.
Studies have shown that over 50 million Americans undergo inpatient surgery each year, and over
80% of surgical patients receive opioids after low-risk surgery.9 In 2012, six of the fifteen most
frequently performed operating room procedures were abdominal surgeries, ranging from
colorectal resection to hysterectomy.11 Considering these statistics, the impact of implementing a
multimodal opioid-sparing regimen in patients undergoing abdominal surgeries would be
significant in the ongoing battle of reducing opioid prescription in the healthcare field.
Consequences of the Problem
The costly economic impact of opioid-related adverse effects stems from increased length
of hospital stay, morbidity, and health care expenses associated with complications.10 Delayed
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recovery time and functional impairment are additional consequences experienced by patients
with inadequately controlled postoperative pain. Follow-up management for surgical patients
with poorly controlled postoperative pain was estimated to be US$1,869±$4,553 per visit.10
Treatment of chronic pain that evolves from acute pain is estimated to cost up to $1 million per
patient.10 Studies suggest that multimodal perioperative care pathways can significantly reduce
postoperative hospital stay and, in turn, decrease hospital costs.5
Objectives of the Systematic Review and Proposed Solution
Considering the known adverse effects of opioids, the national movement to reduce
opioid prescription and misuse, the frequency of abdominal surgeries, and the proven importance
of adequate postoperative pain management, a notable practice question comes to mind: In
patients undergoing open, nonemergent abdominal surgeries (P), does the use of multimodal,
opioid-sparing pain management techniques (I) during the preoperative and perioperative period
(C) reduce postoperative opioid consumption versus non-multimodal pain management (O)?
Opioid-sparing, enhanced recovery after surgery (ERAS) protocols are shown to improve surgical
outcomes; however, widespread implementation has been slow, and practice recommendations
specific to abdominal surgeries are lacking.12 Reducing postoperative opioid requirements while
adequately managing surgical pain will likely decrease hospital length of stay and healthcare
costs, improve patient outcomes, reduce negative opioid side effects, and improve patient
outcomes.5,10 Through an extensive review of existing research, an evidence-based educational
module was created.
The proposed study aims to assess provider knowledge and confidence regarding the use
of non-opioid interventions in the preoperative and intraoperative period that can reduce
postoperative opioid use in patients undergoing open, non-emergent abdominal surgeries.
Through preoperative and intraoperative interventions, as well as regional anesthetic techniques,
opioid use can be significantly reduced. By educating providers on various multimodal analgesic
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methods specific to non-emergent abdominal surgeries, the investigator intends to enhance
provider comfort level in recommending and utilizing these interventions in the healthcare setting
with the goal of improving patient outcomes and reducing opioid use in this surgical population.
METHODOLOGY OF LITERATURE REVIEW
Information Sources and Search Strategy
A literature search of online databases was conducted utilizing PubMed electronic
database, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Excerpta
Medica Database (EMBASE). Search terminology included the following: abdominal OR
abdomen, surgery OR surgical, opioid-sparing OR opioid, enhanced recovery after surgery OR
protocol OR ERAS. The Pubmed, CINAHL, and EMBASE databases produced 207, 304, and 172
results, respectively. After removing duplicates, 228 articles were left for appraisal. The literature
search was current as of November 2020.
Study Selection and Screening Method
A total of 683 articles resulted from the three databases on initial search. Of these, 455
duplicates were removed, and 228 articles remained for appraisal. Titles and abstracts of the
remaining articles were assessed with the following question in mind: In patients undergoing
nonemergent, open abdominal surgeries, does use of multimodal, opioid-sparing pain
management techniques during the preoperative and perioperative period reduce postoperative
opioid consumption versus non-multimodal pain management? Inclusion criteria included fulltext articles, English language articles, randomized controlled trials (RCT), quasi-experimental
studies, and published within the last five years. The patient population was limited to adults and
excluded pediatric patients. Further exclusion criteria included any emergent surgical procedures,
publication before 2015, surveys, case studies, and non-English articles. Anatomical surgical
exclusions included foregut surgeries, cesarean sections, and cardiac procedures.
Twenty-one full-text articles were then assessed for eligibility. Twelve articles were
excluded for various reasons, including only postoperative interventions, no benefit or correlation
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between the intervention and opioid consumption, and intrathecal opioid administration as the
only independent variable. Four found no benefit or correlation between the researched
intervention and opioid consumption. Four of the articles listed intrathecal opioid administration
as the only independent variable and were therefore excluded. One article proved noninferiority;
while the outcome was not worse, it does not show that the intervention was beneficial. A manual
assessment of the search result’s reference list was conducted, and no additional RCTs met the
criteria for this systematic review. Ultimately, nine articles were included in a full literature
review. Appendix A illustrates the literature search and methodology used in the form of a
PRISMA flow diagram.
Table 1. Inclusion and Exclusion Criteria
Inclusion
Population:
• Adults (age 18+)
Type of procedure:
• Abdominal surgeries
• Open incision
Intervention:
• Opioid-sparing protocol or non-opioid analgesic
method aimed at reducing postoperative opioid
consumption
Primary outcomes:
• Decreased opioid consumption
• Reduction in patient-reported pain
Type of study:
• English language
• RCTs
• Quasi-experimental studies
• Meta-analysis
• Publication date 2015-Present

Exclusion
Population:
• Obstetric
• Children (<18 years old)
Type of procedure:
• Emergent
• Cesarean section
• Cardiac surgery
Intervention:
• Intrathecal opioid administration
as only independent variable
Outcomes:
• Noninferiority
• No correlation between
intervention and postoperative
opioid use
Type of study:
• Non-English
• Publication date pre-2015
• Systematic reviews
• Surveys
• Questionnaire
• Dissertations/theses

Collection, Analysis, and Data Items
The selected studies were evaluated in a systematic method. Information obtained
included (1) study design and setting, (2) sample size and characteristics, (3) independent and

10
dependent variables, (4) measurement, (5) data analysis, (6) findings, (7) strengths and
limitations, and (8) study conclusion. This information can be found in Appendix B: Matrix
Table.
The level of evidence rating based on the John Hopkins Research Evidence Appraisal
Tool can also be found in the evaluation table. This tool is used to rank the strength and quality of
research studies, with level I being the highest strength of evidence and V being the poorest
quality.13 Level I includes experimental studies, RCTs, and systematic reviews of RCTs.13 Level
II consists of quasi-experimental studies, systematic reviews of a combination of RCTs and quasiexperimental studies, or quasi-experimental studies only.13 Examples of level III studies are nonexperimental studies and systematic reviews of a combination of RCTs, quasi-experimental and
non-experimental studies, or non-experimental studies only. Within levels I-III of evidence, the
quality is graded with the letters A through C. Grade A is high quality while C is considered low
quality or containing significant flaws. Conclusions cannot be drawn from grade C quality
research. Level IV evidence includes opinions of respected authorities or expert committees, and
level V evidence is based on experiential and non-research evidence; neither is considered highlevel evidence.1
RESULTS OF LITERATURE REVIEW
Study Characteristics
Combined, the selected RCTs, quasi-experimental study, and meta-analysis had a total of
2,498 patients undergoing abdominal surgery who received either the placebo or a non-opioid
intervention. All studies were published between 2015 and 2019 and were printed in English. The
pediatric population was not included in any of the studies. While the type of abdominal surgery
varied, the open abdominal approach was the only method examined in every article but one; the
interventional RCT by Bojhaxi included both open and laparoscopic total pancreatectomies in its
surgical population.20
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Patient demographics. All patients in the studies were scheduled to undergo an elective
abdominal procedure. All patients were at least 18 years of age. Five of the nine articles appraised
excluded patients classified as an ASA IV. Of the four studies that did not exclude patients based
on ASA classification, only 19 total patients were identified as ASA IV. ASA classification was
not discussed in the meta-analysis. Four of the studies excluded participants based on weight or
body mass index (BMI). Pregnancy was an exclusion criterion in all studies, and sample sizes
ranged from 48 to 1207 participants.
Hospital demographics. The hospitals included in the studies appraised are located
around the world. Guo et al. conducted their study at First Affiliated Hospital, School of
Medicine at Zhejiang University in China.14 Sarin et al. performed their study at a tertiary care
teaching hospital site of UCSF- Mount Zion Hospital.15 Neither Kaur et al. nor Wang et al.
specified where their respective studies were conducted.16.17 Purdy et al. performed their trial at
Kuopio University Hospital in Finland.18 Mohamed et al. conducted their study at the South
Egypt Cancer Institute.19 Bojhaxi performed his RCT at the Mayo Clinic in Florida, U.S,A.20
Meyer et al. conducted their 2018 study at MD Anderson.21 Jarahzadeh et al. performed their
double-blind RCT at Shahid Sadoughi Hospital in Yazd, Iran.22
Methodology. The personnel conducting the interventions varied. Registered nurses,
anesthesiologists, nurse anesthetists, and pharmacists were all mentioned, while others did not
specify who was administering the intervention. It is important to recognize that the focus of this
literature review spans the perioperative period; therefore, preoperative staff, operating personnel,
anesthesia providers, and postoperative staff are all included depending on the stage of the
intervention and focus of the study.
Two studies examined the effects of implementing an ERAS protocol in which intraoperative and postoperative opioid-sparing multimodal analgesia was one aspect.15, 21 Those
studies examining intraoperative interventions standardized the general anesthetic technique of
patients in both the control and test groups.14, 16, 18-20, 22 The meta-analysis included high-to-
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moderate quality RCTs and minimized the selective risk of bias; however, different doses and
time intervals of preoperative pregabalin administration varied.17
Collection of data varied among the nine studies regarding the specific dependent
variables (several pain scales were utilized and recording times of opioid administration varied),
but the similarities were significant enough to allow appraisal and comparison. Guo, Sarin, Purdy,
Bojhaxi, and Meyer all utilized a numeric rating scale for pain, ranging from 1-10.14,15,18,20,21
Kaur, Wang, Mohamed, and Jarahzadeh assessed patient pain level using a visual analog
scale.16.17.19.22
All nine articles assessed opioid consumption postoperatively. Guo assessed cumulative
narcotic use from five min postoperative to 48 hours.14 Sarin et al. assessed median opioid
consumption intraoperatively, as well as postoperative day 0 through 2.15 Kaur et al. assessed
total morphine usage within 24 hours.16 Wang et al. reported total morphine consumption up to 48
hours following abdominal hysterectomy.17 Purdy et al. looked at numerical values of opioid
consumption.18 Mohamed et al. assessed morphine consumption as well as the time to first
request for analgesia.19 Bojhaxi assessed total opioid consumption.20 Meyer et al. assessed median
intraoperative and postoperative opioid dosages.21 Jarahzadeh et al. assessed mean narcotic
consumption.22 Though the exact methodology of assessing opioid consumption varied, the
results wholly reflected a decrease in opioid usage versus placebo groups.
Definitions and Findings of Outcomes
This systematic review aims to evaluate the effect of multimodal opioid-sparing
interventions in various preoperative stages on postoperative opioid consumption. Patientreported pain levels were a common outcome assessed in conjunction with narcotic usage.
Secondary outcomes included a reduction in nausea and vomiting, decreased time to first meal,
first ambulation, and foley removal, and increased patient satisfaction. Table 2 summarizes the
data collected and each study’s outcomes. Table 2 also displays the strengths and weaknesses of
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each study, as well as the level of evidence. Small sample size was a recurrent weakness in the
articles appraised.
Table 2. Studies Included in the Appraisal
Author (Year)
& Level of
Evidence
Guo et al. (2018)
Level I
Grade B

Study, Participants, &
Interventions

Findings in Intervention Group(s)

70 ASA I-III patients, 18-65 years
old, undergoing scheduled open
liver resection
bilateral ultrasound-guided
OSTAP blocks with either 0.375%
ropivacaine (group T) or 0.9%
isotonic saline (group C)

Sarin et al.
(2015)
Level II Grade B

279 patients undergoing
abdominal colorectal surgery in
the ERAS program compared to
245 patients undergoing surgery
prior to ERAS implementation

Kaur et al.
(2015)
Level I
Grade B

80 patients undergoing open
cholecystectomy.
ASA I-II
Age 21-50
Low dose ketamine infusion
(group K) versus saline (group C)

NRS score rest: Reduced postoperative
pain scores in Group T
NRS score cough: lower in group T
than in group C at all time points
except 5 min after extubation
Intraoperative sufentanil: significantly
less in group T than in group C
Cumulative sufentanil (5 min-24 hour
postop): lower in group T than Group
C
Cumulative fentanyl use at 48 hours:
no significant difference
Median opioid consumption
intraoperative: reduced opioid
consumption in ERAS group (p<
0.001)
Median opioid consumption POD 0-2:
reduced in ERAS group (p < 0.001)
Self-reported pain scores: reduced in
ERAS group POD 0 and 1.
Total morphine used within 24 hours
was lower in the group with ketamine
vs. control
Reduced postoperative pain scores

Wang et al.
(2017)
Level I
Grade B

1207 patients
Age 18+
Preoperative pregabalin for
managing pain after hysterectomy
versus placebo

Purdy et al.
(2018)
Level I
Grade B

57 patients undergoing midline
laparotomy
Age 18-80
BMI 18-35
Independent variables: single-dose
rectus sheath block (RSB),
repeated dose RSB, continuous
infusion RSB, or control group

Reduced VAS at 2, 4, and 24 hours
with rest and mobilization.
Total morphine consumption reduced.
Reduced nausea and vomiting.
No difference in sedation; increased
occurrence of dizziness.
First 12 hours post-op
: oxycodone consumption was less in
the infusion and repeated-doses groups
than in the single-dose and control
groups (P=.07)
Numerical values of oxycodone
consumption at 48 hours post-op less
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Mohamed et al.
(2018)
Level I
Grade B

Bojhaxi (2019)
Level I
Grade B

Meyer et al.
(2018)
Level II
Grade B

Jarahzadeh et al.
(2016)
Level I
Grade B

90 patients undergoing total
abdominal hysterectomy with low
midline vertical incision
ASA I-II
Age 18-80
Weight 50-85 kg
Local wound infiltration with
ketamine and bupivacaine (group
K), dexmedetomidine and
bupivacaine (group D), or control
(bupivacaine only) after skin
closure and before extubation
48 patients undergoing elective
open or laparoscopic total
pancreatectomies
ASA I-III
Age 18-80
BMI <40
Intervention: lidocaine infusion
from induction through time that
patient meets discharge criteria
from recovery, placebo
533 patients in cohort, 74 patients
in historical control
Age 18-85
Undergoing open abdominal
surgery for gynecologic
indications
Comparing those receiving ERAS
protocol versus those undergoing
surgery before its implementation
60 patients in
Age 35-65
Undergoing abdominal
hysterectomy
ASA I-II
intravenous magnesium sulfate
infusion versus placebo

in the repeated-doses group, but
median was similar.
Repeated-doses group performed
better at the first 4h after surgery when
coughing than the control group
Repeated-doses group performed
better at rest than other 3 groups at 12
and at 24 hr.
PCA morphine consumption: less in
group K and group D than group C
Time to first request analgesia:
prolonged in group K and group D
Mean VAS-R score: reduced in group
K compared to group C in first 24
hours; reduced in group D compared
to group C in first 8 hours

Pain in postoperative period was less
in the group receiving lidocaine
infusion (P= 0.1459)
Total opioid consumption in mg was
less in the group receiving lidocaine
infusion (P = 0.2050)

No difference in pain scores reported,
however,
intraoperative and postoperative opioid
use was lower in ERAS group.
Median intraoperative opioid dose was
reduced 39% in ERAS group
Postoperative opioid dose was reduced
83%, 80%, 71%, and 50% on POD 0,
1, 2, and 3, respectively
Mean pain scores at all time points
were lower in study group than
placebo group.
Means of narcotic consumption were
higher in placebo for all measured
time points
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Attenuation of opioid consumption. All nine articles appraised found that the studied
intervention reduced postoperative opioid consumption to some degree. The 2017 meta-analysis
by Wang et al. found that preoperative pregabalin had opioid-sparing effects versus the placebo
group; morphine consumption was measured at 2, 4, 24, and 48 hours after hysterectomy.17 Both
the 2015 RCT conducted by Sarin et al. and the 2018 RCT performed by Meyer et al. examined
the effect of multifaceted ERAS protocols on opioid consumption.15,21 Meyer et al. ERAS group
had a 72% reduction in median opioid consumption when compared to those before
implementation of the ERAS protocol.21 Furthermore, 16% of patients on the ERAS protocol
were opioid-free from the first postoperative day to the third postoperative day, versus no patients
in the pre-ERAS comparison group.21 Median opioid consumption in the study by Sarin et al.
decreased in the ERAS group compared to the pre-ERAS group both intraoperatively and
postoperatively.15
Amongst the articles examining an intraoperative intervention, a reduction in
postoperative opioid consumption was also seen. Two articles examined regional techniques:
rectus sheath block analgesia (RSB) and subcostal transversus abdominis plane block.14,18 Purdy
et al. conducted a RCT in which patients either received single dose, repeated dose, or continuous
infusion RSB analgesia. Repeated doses of levobupivacaine showed opioid-sparing efficacy.18
Guo et al. found that intraoperative sufentanil use as well as cumulative sufentanil use at five
minutes post-extubation and 2, 4, 12, and 24 hours after operation in those who received bilateral
ultrasound-guided OSTAP blocks were all less than the control group.14 The 2018 RCT
performed by Mohamed et al. examined local wound infiltration with ketamine and
dexmedetomidine.19 Both interventions significantly reduced PCA morphine consumption,
prolonged time to first rescues analgesia, and fewer total rescue analgesia doses compared to the
control group.19
Bojhaxi found that intravenous lidocaine infusion reduced mean opioid consumption at 4
hours and 24 hours postoperative.20 The 2015 RCT by Kaur et al. reported that intraoperative
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ketamine infusion reduced cumulative morphine consumption over 24 hours.16 Jarahzadeh et al.
found the mean value of narcotic consumption at each time point (1, 2, 6, and 12 hours after
surgery) to be higher in the placebo group versus those who received intravenous magnesium
sulfate.
Attenuation of reported pain score. Each of the nine articles found that the respective
intervention reduced patient-reported pain levels. The 2017 meta-analysis by Wang et al. found
that preoperative pregabalin reduced visual analog scale (VAS) score at 2, 4, and 24 hours
postoperatively, both at rest and with mobilization.17 The 2015 RCT conducted by Sarin et al.
showed improvements in early postoperative pain scores.15, Meyer et al. found that the ERAS
group did not have higher pain scores despite significantly reduced opioid consumption.21
Of the articles examining regional techniques, each improved patient pain on the pain
scales utilized. Purdy et al. found that patients’ satisfaction with pain management was higher in
the repeated-doses group (the same technique that demonstrated opioid-sparing efficacy).18 In the
study conducted by Guo et al., OSTAP block significantly reduced postoperative numeric rating
scale (NRS) pain scores at rest and with coughing compared to the control group.14 Both local
wound interventions performed by Mohamed et al. significantly reduced mean VAS-R score
when compared to the control group.19 There was no significant difference between the ketamine
group and the dexmedetomidine group.19
Bojhaxi found that intravenous lidocaine infusion reduced patient reported pain on the
NRS scale.20 The RCT conducted by Kaur et al. reported that patients receiving intraoperative
ketamine had less pain than the control group on VAS during the first 6 hours, although there was
no significant difference in the groups at 24 hours.16 Jarahzadeh et al. found the pain patients
experienced was significantly less in the study group receiving magnesium versus the placebo
group.22
Secondary outcomes. Numerous benefits of opioid-sparing analgesic techniques were
found beyond the primary outcomes of reduced postoperative opioid consumption and reduction
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in patient reported pain. The 2017 meta-analysis by Wang et al. found that preoperative
pregabalin significantly reduced the occurrence of nausea (9.91%) and vomiting (8.83%).17
Meyer et al. ERAS group had a 25% reduction in median length of stay, less fatigue, and less
self-reported interference with walking during hospitalization when compared to those before
implementation of the ERAS protocol.21 Median total hospital length of stay and 30-day
readmission rate were decreased in the ERAS group when compared to the historical control
group in the study conducted by Sarin et al.15. Furthermore, median time to first solid meal,
median duration for urinary catheterization, and subjective reporting of nausea/vomiting were all
reduced in the ERAS group.15
In the study by Guo et al. examining OSTAP block efficacy in patients undergoing
abdominal surgery, the control group had a higher incidence of nausea and vomiting.14 Stress
responses to postoperative pain elicit changes in hormonal secretion; for this reason, the RCT
performed by Mohamed et al. assessed serum glucose, prolactin, and cortisol levels
preoperatively and postoperatively.19 Mean cortisol, prolactin, and glucose levels were
significantly lower in the groups receiving local wound infiltration with ketamine and
dexmedetomidine compared to the control group at 6 and 24 hours postoperatively.19 At 24 hours
postoperatively, the hormone levels tested were significantly lower in the ketamine group
compared to the dexmedetomidine group. Both interventions significantly reduced PCA
morphine consumption, prolonged time to first rescues analgesia, and fewer total rescue analgesia
doses compared to the control group.19
DISCUSSION OF LITERATURE REVIEW
Summary of Evidence
Following an extensive literature review, nine studies with a total of 2,498 patients were
included in this systematic review. One article was rated as Level I, grade A. This is the highest
level of evidence and quality. Six of the articles were rated as Level I, grade B; the ‘B’ reflects
the quality. Grade B is good quality with reasonably consistent results and sufficient sample
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size.13 While the smaller sample sizes were adequate for each individual RCT, whether the results
are able to be generalized to a larger population could be debated. The two quasi-experimental
studies reviewed were rated as Level II, Grade B based on design. The results of the systematic
review are summarized below, in order by time of intervention and technique:
-

One meta-analysis found analgesic efficacy and opioid-sparing effects with preoperative
use of pregabalin.

-

Two quasi-experimental studies examining ERAS protocols found that preoperative and
intraoperative non-opioid analgesics (neuraxial anesthesia, ketamine, acetaminophen,
gabapentin, and COX-inhibitors) reduced postoperative opioid usage.

-

One RCT found that IV magnesium sulfate infusion reduced pain and postoperative
opioid consumption.

-

One RCT found intraoperative low-dose ketamine infusion provides postoperative
analgesia while reducing the need for opioid analgesics.

-

One RCT found that intravenous lidocaine reduced mean opioid consumption.

Regional techniques
-

A single study reported that oblique subcostal transversus abdominus plane blockade
significantly decreased cumulative dosage of analgesics with Mercedes incision.

-

One study stated that rectus sheath block analgesia with repeated doses had an opioid
sparing effect after midline laparotomy.

-

One study showed that local wound infiltration with ketamine or dexmedetomidine added
to bupivacaine has an opioid-sparing effect after abdominal hysterectomy.

Limitations of Review
Several limitations to this systematic review must be acknowledged. The aim of this review
was to examine both preoperative and intraoperative opioid-sparing analgesic techniques and
their effects on open abdominal surgeries. Rather than reviewing several studies on a single
intervention, multiple interventions throughout the perioperative period were examined. The
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purpose was to compile a systematic review that offers anesthesia providers various options and
interventions based on the patient, surgeon, surgery, facility, medication availability, and
individual practice. This was not intended to provide a “one-size-fits-all” recipe for opioidsparing analgesia in abdominal surgeries, but instead a diverse compilation of proven
interventions; therefore, several dissimilarities existed between the nine studies reviewed.
The inclusion criteria of “articles published in English” has the potential to produce language
bias. The variability in each studies’ focus led to subsequent inconsistencies in participants and
data collection. While several studies specified ASA classification, four did not utilize this metric
as an inclusion or exclusion criterion. The same can be said about participants’ BMI ranges.
Another limitation was the number of study participants. In the six RCTs, the number of patients
ranged from 48 to 90. In the two quasi-experimental design studies, there were 279 and 533
participants. The meta-analysis examining preoperative pregabalin usage has 1207 patients. Time
intervals for data collection also greatly varied from study to study, as well as the secondary
outcomes measured.
Summary of Review
After appraising the selected articles, the evidence showed that each non-opioid analgesic
intervention of focus could reduce postoperative opioid consumption in adults undergoing nonemergent open abdominal surgery. This systematic review examined several modalities that have
a favorable effect not only on postoperative opioid use and pain scores, but also on patient
satisfaction and postoperative nausea and vomiting. The utilization of these interventions,
whether independently or in combination, has the potential to lead to a multitude of positive
patient outcomes. The opioid epidemic in this country is a challenge that the U.S. healthcare
system continues to face. The knowledge of non-opioid methods outlined in this systematic
review offer positive outcomes for patients as well as hospital systems. Non-opioid analgesic
methods are indeed effective at reducing opioid consumption, and, in the face of an ongoing
epidemic and push for evidence-based practice, a shift in current practice is indicated.
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PICO and Purpose
The purpose of the study is to assess provider knowledge and confidence regarding the
use of non-opioid interventions in the preoperative and intraoperative period to reduce
postoperative opioid consumption. Based on the systematic review performed and the conclusions
drawn from the article appraisal, an educational video was composed. The proposed PICO
question for this study is the following: If CRNAs are provided an online educational module on
opioid-sparing pain management techniques during the preoperative and perioperative period that
reduce postoperative opioid consumption for patients undergoing open, nonemergent abdominal
surgeries, will change occur in their knowledge and confidence?
METHODOLOGY OF QUALITY IMPROVEMENT
Settings and Participants
The study takes place at a level 1 trauma center in southeast Florida. Primary study
participants include CRNAs employed by the anesthesia group that staffs this facility. The
participants are recruited voluntarily via an email list provided by the hospitals’ Anesthesia
Department. They will receive the proposed intervention and provide feedback regarding their
experience and learning through an anonymous survey. The anticipated sample size is ten adult
participants of both genders.
Description of Approach and Subject Procedures
The primary methodology of the proposed project is to administer an online educational
intervention to anesthesia providers that focuses on preoperative and intra-operative methods to
reduce postoperative opioid consumption in adult patients undergoing abdominal surgery. With
written consent, the participants will complete an anonymous pre-test survey to assess their
knowledge and current clinical practices regarding non-opioid analgesic methods and their role in
reducing postoperative opioid consumption in patients undergoing open, non-emergent abdominal
surgeries in adults. The survey will be completed individually and is expected to take up to 5-15
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minutes to complete. This will identify providers’ existing knowledge and will determine whether
learning took place following the intervention.
Next, the participants will complete an educational PowerPoint presentation based on the
results of the systematic review described in the previous section. Implementation of acute and
chronic pain management modalities fall within the responsibilities of a CRNA. It is important
that providers have the knowledge to effectively utilize various analgesic methods in the
preoperative and intraoperative periods to reduce postoperative opioid consumption. The
evidence supports the need for a project with comprehensive information regarding opioidsparing analgesic methods specific to abdominal surgery.
The third phase of the project asks participants to complete the post-test, which will be
identical to the pre-test. The post-test survey is expected to take up to 5-15 minutes to complete.
This information will provide feedback regarding the impact of the educational intervention and
whether learning took place amongst participants. The pre/post-testing will provide relevant
information regarding the effectiveness of this online intervention in influencing CRNAs’
practice.
Protection of Human Subjects
For this study, the recruitment population will include the southeast Florida hospital
systems’ CRNAs. This population is directly responsible for the delivery of anesthesia to
thousands of patients in South Florida every year and can influence the care provided to patients
undergoing abdominal surgery in their respective facilities. Recruitment activities are conducted
by email invitations to providers on the email list provided by the hospital’s anesthesia
department. There will be no penalties if any participants decide to withdraw from the quality
improvement project at any stage. Participants are not expected to experience any risks, harms, or
discomforts through participation in this project. Potential benefits to participants include
improved knowledge of preoperative and intraoperative opioid-sparing interventions that can
reduce postoperative opioid consumption in adults undergoing open, non-emergent abdominal
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surgeries. There will be no compensation or incentives. This study only requires the time spent by
each participant in the educational intervention.
Data Collection
For the study, the primary method used will include pre-assessment and post-assessment
testing applications to determine the effects of the educational intervention. Both tests are
identical and will be conducted using surveys that will determine participants’ understanding of
non-opioid interventions in the preoperative and intraoperative period that can reduce
postoperative opioid use in patients undergoing open, non-emergent abdominal surgeries. It will
also determine the efficacy of a PowerPoint educational intervention to meet this objective.
The survey consists of 12 questions that focus on knowledge and clinical interventions
using Qualtrics. In this manner, the pre-test survey will gauge each providers’ foundational
knowledge of opioid-sparing techniques in this surgical population. The post-test survey will
determine if learning took place amongst participants and whether they will apply any gained
knowledge to their practice environment. The reliability and validity will be measured in
accordance with the intervention and its effectiveness. The data collected will be confidential and
anonymous, and no identifiable private information will be collected during any component of the
study. Demographic data, including gender, age, ethnicity, and title, will be obtained as part of
the survey.
Data Management and Analysis Plan
The co-investigator for the project will be the DNP student who is responsible for
administering the survey. To evaluate the responses provided on the pre-test and the post-test,
SPSS software will be used to determine if participants have received knowledge and gained
confidence. Each question will be measured, and the responses recorded to identify the
knowledge base before and after the intervention. No personal identifiers will be recorded for
study participants, and confidentiality will be protected. The impact of the intervention will be
based upon the results of the pre-test and post-test survey instruments. Through statistical
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analysis, the study results will likely identify patterns that will be used to determine the
effectiveness of educational intervention and how it affects CRNAs’ actions and behaviors. The
co-investigator will store the data collected in a password-protected laptop computer.
RESULTS OF QUALITY IMPROVEMENT
Demographics
The demographics are shown in Table 3, below.
Table 3: Demographics
Total Participants
Gender
Male
Female
Age
18-29
30-49
>50
Ethnicity
Caucasian
Other
Position
CRNA
No response
Education
Masters
Doctorate

n (%)
9 (100%)
2 (22.22%)
7 (77.78%)
1 (11.11%)
5 (55.56%)
3 (33.33%)
7 (77.78%)
2 (22.22%)
5 (55.56%)
4 (44.44%)
3 (33.33%)
6 (66.67%)

There were nine participants in the study and survey. The majority of the participants
were female (n=7, 77.78%), as opposed to male (n=2, 22.22%). Ethnicities represented were
Caucasian (n=7, 77.78%) and other (n=2, 22.22%). Five of the participants were CRNA’s, and
four did not answer. It must be noted that the survey was only sent out to CRNAs employed by
the specified South Florida hospital; therefore, everyone who had access to the survey was a
CRNA. Age of participants ranged from 18-29 years old (n=1, 11.11%) to 50+ years old (n=3,
33.33%). Fifty-five percent of survey participants fell into the 30-49 years old age range (n=5).
Highest level of education included master’s degree (n=3, 33.33%) and doctorate degree (n=6,
66.67%).
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Pre-Test Findings
The pre-test gauged participants’ starting knowledge regarding opioid use, surgical pain,
and interventions to reduce opioid use in surgical patients undergoing abdominal surgery. The
majority of participants were aware that postoperative pain is one of the most commonly cited
fears of patients scheduled for surgery (n= 6, 66.67%). Only 22.22% of CRNAs surveyed knew
that the U.S. government declared the opioid epidemic a public health emergency in 2017. When
asked about consequences of postoperative pain, 66.67% of the participants knew that nausea and
vomiting was not directly related to ineffectively controlled postoperative pain. The majority of
participants knew that 80% of surgical patients receive opioids after low-risk surgery (n=5,
55.56%). Only one CRNA knew that treatment of chronic pain that evolves from acute pain is
estimated to cost up to $1,000,000 per patient— the majority selected $250,000 or $500,000
(n=6, 66.67%).
The costly economic impact of opioid-related adverse effects stems from multiple
factors: increased length of hospital stays, functional impairment, and morbidity. Three
participants correctly identified all three factors, two participants identified two of the three, and
two identified one of the three. The majority of participants knew that withholding opioids and
other analgesics from surgical patients intraoperatively could lead to an increase in chronic pain
evolving from poorly managed acute pain (n=6, 66.67%). Secondary outcomes of reduced
postoperative opioid consumption include decreased time to first meal, decreased nausea and
vomiting, and increased patient satisfaction. Two participants selected all three correctly
(22.22%), three selected two of the choices correctly (33.33%), and one selected one of the
choices correctly (11.11%). The incidence of opioid abuse postoperatively varies based on age,
genetics, medical history, and surgical procedure. The fifth and incorrect answer choice was
weight. One survey participant incorrectly selected all five (11.11%), two correctly selected all
four answers (22.22%), three selected three of the four correct choices (33.33%), one selected two
of the four correct choices (11.11%), and one selected one of the four correct choices (11.11%).
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One participant did not correctly select any of the answers (11.11%). Five participants knew that
intravenous lidocaine infusion reduces mean opioid consumption (55.56%).
Pre-Test Confidence
The pre-test found that four CRNAs felt extremely comfortable recommending/ordering
one of the studied preoperative non-opioid interventions in order to reduce opioid usage
postoperatively (44.44%), three felt somewhat comfortable (33.33%), and two felt neither
comfortable nor uncomfortable. Similarly, three CRNAs surveyed were extremely likely to
recommend one of the studied intraoperative non-opioid interventions in order to reduce
postoperative opioid usage postoperatively (33.33%). Three CRNAs were somewhat likely to
make recommendations (33.33%), and three were neither likely nor unlikely (33.33%).
Post-Test Findings
The same nine participants that completed the pre-test also participated in a post-test
survey. The post-test gauged participants’ knowledge regarding opioid use, surgical pain, and
interventions to reduce opioid use in surgical patients undergoing abdominal surgery after
viewing an educational module. Majority of participants correctly chose postoperative pain as one
of the most commonly cited fears of patients scheduled for surgery (n= 8, 88.89%). Eight CRNAs
surveyed knew that the U.S. government declared the opioid epidemic a public health emergency
in 2017 (88.89%). In the post-test, 77.78% of survey participants knew that increased nausea
vomiting was not directly related to ineffectively controlled postoperative pain. Majority of
participants knew that 80% of surgical patients receive opioids after low-risk surgery (n=8,
88.89%). Six CRNA’s now knew that treatment of chronic pain that evolves from acute pain is
estimated to cost up to $1,000,000 per patient (n=6, 66.67%)—in the pre-test, only one person
selected the correct answer.
As previously mentioned, the costly economic impact of opioid-related adverse effects
stems from multiple factors: increased length of hospital stays, functional impairment, and
morbidity. Five participants correctly identified all three factors (55.56%), two participants
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identified two of the three (22.22%), and two identified one of the three (22.22%). The majority
of participants knew that withholding opioids and other analgesics from surgical patients
intraoperatively could lead to an increase in chronic pain evolving from poorly managed acute
pain (n=7, 77.78%). Again, secondary outcomes of reduced postoperative opioid consumption
include decreased time to first meal, decreased nausea and vomiting, and increased patient
satisfaction. Six participants selected all three correctly (66.67%), and one selected one of the
choices correctly (11.11%). One person selected all three correct answers but also chose a fourth
incorrect answer (11.11%). Five survey participants correctly selected the four patient factors that
influence postoperative opioid abuse (55.56%). One person incorrectly selected all five answer
choices (11.11%), one person selected three of the four correct choices (11.11%), and one person
selected two of the four correct choices (11.11%). Seven participants knew that intravenous
lidocaine infusion reduces mean opioid consumption (77.78%) as opposed to five people in the
pre-test. Table 4 shows the differences in responses from pre- to post-test.
Table 4: Difference in Pre- and Post-Test Findings
One of the most commonly cited fears of patients
scheduled for surgery is the fear of pain.
The U.S. Government declared the opioid epidemic a
public health emergency in 2017.
Ineffectively controlled postoperative pain is related to
all of the following except increased nausea and
vomiting.
Over 80% of surgical patients receive opioids after
low-risk surgery.
Treatment of chronic pain that evolves from acute pain
is estimated to cost up to $1,000,000 per patient.
The costly economic impact of opioid-related adverse
effects stems from increased length of hospital stay,
functional impairment, and morbidity.
Withholding opioids and other analgesics from
surgical patients intraoperatively could lead to an
increase in chronic pain evolving from poorly
managed acute pain.
Secondary outcomes of reduced postoperative opioid
consumption are decreased time to first meal,
decreased nausea and vomiting, and increased patient
satisfaction.

Pre-test
66.67%

Post-test
88.89%

Difference
22.22%

22.22%

88.89%

66.67%

66.67%

77.78%

11.11%

55.56%

88.89%

33.33%

11.11%

66.67%

55.56%

33.33%

55.56%

22.23%

66.67%

77.78%

11.11%

22.22%

66.67%

44.45%
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The incidence of opioid abuse postoperatively varies
based on age, genetics, medical history, and surgical
procedure.
True: Intravenous lidocaine infusion reduced mean
opioid consumption.

22.22%

55.56%

33.34%

55.56%

77.78%

22.22%

As seen in Table 4, learning took place on every question to varying degrees.
Significantly more CRNAs recognized when the opioid epidemic became a public health
emergency, the drastic cost of treating chronic pain that evolves from acute pain, and the
secondary outcomes of reduced postoperative opioid consumption. Those questions in which a
stronger starting knowledge existed (most commonly cited fears of surgical patients, factors
related to ineffectively controlled postoperative pain, and the harm of withholding opioids and
analgesics) saw a smaller margin of improvement when compared to the post-test. All
participants selected more correct answers in the post-test than pre-test.
Post-test Confidence
The post-test found that eight CRNAs felt extremely comfortable
recommending/ordering one of the studied preoperative non-opioid interventions in order to
reduce opioid usage postoperatively (88.89%). Nine CRNAs surveyed were extremely likely to
recommend one of the studied intraoperative non-opioid interventions in order to reduce
postoperative opioid usage postoperatively (100%). Table 5 shows the differences in responses
from pre- to post-test.
Table 5: Difference in Pre- and Post-Test
Confidence
How comfortable are you with
recommending/ordering one of the studied
preoperative non-opioid interventions for a patient
undergoing open non-emergent abdominal surgery?
How likely are you to recommend one of the studied
intraoperative non-opioid interventions in order to
reduce opioid usage postoperatively?

Pre-test

Post-test

Difference

44.44%

88.89%

44.45%

33.33%

100%

66.67%

As shown in Table 5, confidence in recommending both preoperative and intraoperative
non-opioid interventions to reduce opioid usage postoperatively significantly improved following
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this educational module. When asked about the preoperative opioid-sparing modalities discussed,
88.89% of study participants stated they were extremely comfortable recommending or ordering
the interventions, while 100% would recommend or utilize one of the intraoperative
interventions. With education, participants were more likely to advocate for opioid-sparing
analgesic interventions to improve postoperative outcomes for patients undergoing on-emergent
abdominal surgery.
Summary
Overall, the results show that there was a difference from pre-test to post-test. There was
an increase in knowledge for every question, as well as an increase in confidence. See Graph 1,
Table 6, and Graph 2 below for visual representations of the study’s findings.
Graph 1

Pre-Test/Post-Test Knowledge
9
8
7
6
5
4
3
2
1
0

Pre-Test

Post-Test

Table 6

Score

N
9

Score

N
9

Pre-Test Knowledge
Mean
4.22
Post-Test Knowledge
Mean
7.44

Std. Deviation
2.86
Std. Deviation
3.17
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Graph 2
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DISCUSSION OF QUALITY IMPROVEMENT
Limitations of Study
Limitations of the study include the small sample size. The study was done using an
anesthesia group in South Florida. A larger group would have been preferable to increase the
strength of the study. The delivery method was another significant limitation. The email list
provided by the participating anesthesia group was not updated; several email addresses on the
distribution list were no longer valid, and more recently hired staff was not included.
Furthermore, self-selection bias was also present. Survey recipients were allowed to decide
entirely for themselves whether they participated or not.
Future Implications to Advanced Nursing Practice
The outcomes of the study are important in demonstrating the importance of education in
empowering providers to administer interventions to support patients. As the world becomes
increasingly technology-driven, utilizing online videos and resources as an educational tool could
indeed be effective; this educational module successfully expanded knowledge and confidence of
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the participating CRNAs in the topic. The impact of the intervention could have a positive effect
on patient outcomes following non-abdominal surgery. The CRNAs that participated have
increased knowledge and confidence regarding preoperative and intraoperative non-opioid
analgesic techniques that can reduce postoperative opioid consumption. Utilizing this information
could lead to improved outcomes in this surgical population.
CONCLUSION
After appraising the nine selected articles, the evidence showed that several non-opioid
analgesic interventions can reduce postoperative opioid consumption. The utilization of these
interventions, whether independently or in combination, has the potential to lead to a multitude of
positive patient outcomes. Non-opioid analgesic methods are indeed effective at reducing opioid
consumption as well as opioid-related adverse effects, and in the face of an ongoing epidemic and
push for evidence-based practice, a shift in current practice is indicated.
An educational module was created based on this systematic review and implemented via
a pre-test and post-test. The implementation led to a significant increase in providers knowledge
and confidence of opioid-sparing analgesic methods in patients undergoing non-emergent open
abdominal surgery. However, further research is needed to focus on additional non-opioid
analgesic interventions in various surgical populations and how best to distribute this information
to CRNAs that are currently practicing.
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Appendix A: PRISMA Flow Diagram

Design and
Setting

Prospective,
observer
blinded,
randomized
control trial.
First
Affiliated
Hospital,
School of
Medicine,
Zhejiang
University
in China

Quasiexperimental
design
(historical
control
group)
Conducted
at a tertiary
care
teaching
hospital site
of UCSFMount Zion
Hospital

Author(s)
and year

Guo et al.
(2018)

Sarin et al.
(2015)

Independent:
bilateral
ultrasound
guided OSTAP
blocks with
either 0.375%
ropivacaine
(group T) or
0.9% isotonic
saline (group C)
Dependent:
NRS score at
rest, NRS score
at cough,
intraoperative
sufentanil use

Independent:
ERAS protocol
Dependent:
postoperative
pain scores,
median opioid
consumption
intraoperatively
and
postoperatively
in milligrams
(mg) oral
morphine
equivalents

279 patients in
the ERAS
program
compared to 245
patients
undergoing
surgery prior to
ERAS
implementation
Abdominal
colorectal
surgery

Variables

70 patients
ASA I-III
Age 18-65
Undergoing
scheduled open
liver resection
BMI 18-26

Sample size and
characteristics

Verbal numeric
postoperative
pain scores (010)
Opioid
consumption
(intraoperatively
and POD 0 to 2)

Verbal numeric
rating scale
(NRS)
Intraoperative
and
postoperative
sufentanil use

Measurement

t-tests, Mann–
Whitney U
tests, Fisher’s
exact tests.
Analyses
performed
using R
version 3.1.2

SPSS 19.0
software
KolmogorovSmirnov test
Parametric
data expressed
as mean with
95%
confidence
intervals.
Nonparametric
data as median
with
interquartile
range.
Group means
compared
using the
Student's t-test
or the Mann–
Whitney U
test

Data Analysis

This
multidisciplinary,
evidence-based,
enhanced recovery
after surgery (ERAS)
program showed an
improvement in pain
control and reduced
opioid consumption
in patients
undergoing
abdominal colorectal
surgery.

Strengths: ERAS
protocol can
reduce opioid
consumption
following
colorectal
surgery.
Limitations:
different rates of
smoking and
HTN in preERAS and ERAS
groups. Resource
constraints in
finding controls
due to new
electronic
medical system.

Median opioid
consumption
intraoperative: reduced
opioid consumption in
ERAS group (p<
0.001)
Median opioid
consumption POD 0-2:
reduced in ERAS
group (p < 0.001)
Self-reported pain
scores: reduced in
ERAS group POD 0
and 1.

Ropivacaine OSTAP
blockade improved
perioperative
analgesia with
decreased opioid use
both intraoperatively
and postoperatively.

Strength:
Findings were
consistent with
existing
investigations
on upper
abdominal
surgery with a
bilateral
OSTAP
blockade.
Limitations: No
measurement
plasma
ropivacaine
concentrations,
no follow-up
beyond hospital
discharge,
population with
“normal” BMI
and ASA I-III
only

NRS score rest:
Reduced postoperative
pain scores in Group T
NRS score cough:
lower in group T than
in group C at all time
points except 5 min
after extubation
Intraoperative
sufentanil: significantly
less in group T than in
group C
Cumulative sufentanil
(5 min-24 hour
postop): lower in group
T than Group C
Cumulative fentanyl
use at 48 hours: no
significant difference

Conclusion

Appraisal

Findings

Level II
Grade B

Level I
Grade B

Level of
Evidence
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Appendix B: Matrix Table

Double
blind
Randomized
control trial.
Conducted
at university
hospital.

Metaanalysis of
RCT

Randomized
control trial
Kuopio
University
Hospital,
Kuopio,
Finland

Kaur et al.
(2015)

Wang et al.
(2017)

Purdy et
al. (2018)
Independent:
single dose
rectus sheath
block (RSB),
repeated dose
RSB,
continuous
infusion RSB,
or control group
Dependent:
opioid
consumption,
pain score

Independent:
Preoperative
pregabalin or
placebo
Dependent:
morphine
consumption,
pain score,
morphinerelated
complications

1207 patients
Age 18+
Preoperative
pregabalin for
managing pain
after
hysterectomy

57 patients
undergoing
midline
laparotomy
Age 18-80
BMI 18-35

Independent:
Ketamine
(group K),
saline (group C)
Dependent: pain
scores at rest at
2, 4-, 6-, 12-,
and 24-hours
post-surgery,
total number of
patients
requiring
morphine and
total morphine
given in 24
hours

80 patients
undergoing open
cholecystectomy.
ASA I-II
Age 21-50

SPSS 11.5
software

Stata
software,
version 13.0
Chi-squared
test
and I2statistic
Funnel plot
Begg test

Mann–
Whitney U
Analysis of
variance
(ANOVA).
Kruskall–
Wallis test
Analyzed
using IBM
SPSS 23.0.

VAS (0 = no
pain and
100 = worst pain
imaginable)
Opioid
consumption

VAS score.
Opioid
consumption.

Pain at rest,
dynamic pain
experienced
when wound
area pressed
with 20N force,
pain when
coughing (all
using Numeric
rating scale 010)
Opioid
consumption

Level I
Grade A

Level I
Grade B

Preoperative
pregabalin has
analgesic efficacy
and opioid-sparing
effects. Significant
decrease in nausea
and vomiting was
associated with use
of pregabalin as well.

Pain relief was
superior in the
repeated-doses RSB
group. Early opioid
consumption for
rescue analgesia was
less in the repeateddoses and continuous
infusion groups than in
the single bolus and
control groups. The
use of RSB may be a
feasible aspect of
multimodal analgesia
treatment after midline
laparotomy.

Strengths:
Pregabalin has an
opioid-sparing
effect, and offers
other benefits
Limitations:
doses vary,
optimal dose
should be
determined, only
10 RCTs,
different followup durations
Strengths:
surgical
operations varied
(gastrointestinal,
gynecological,
and urological
cases) and
reflects the
situation in
normal clinical
practice.
Limitations: no
invasive placebo
led to lack of
blinding, small
sample size

Reduced VAS at 2, 4,
and 24 hours with rest
and mobilization.
Total morphine
consumption reduced.
Reduced nausea and
vomiting.
No difference in
sedation, increased
occurrence of dizziness.

First 12 hours post-op:
oxycodone consumption
was less in the infusion
and repeated-doses
groups than in the singledose and control groups
(P=.07)
Oxycodone consumption
at 48 hours post-op less
in repeated-doses group.
Repeated-doses group
performed better at the
first 4h after surgery
when coughing and at
rest than the control
group.

Level I
Grade B

Low-dose ketamine
infusion provided
postoperative
analgesia while
reducing need of
opioid analgesia

Strengths:
Ketamine related
adverse effects
are rare under
general
anesthesia.
Opioid-sparing
effect could be
useful in opioid
intolerant and
cancer patients.
Limitations:
could not use
high dose
ketamine due to
potential
psychomimetic
effects

Total morphine used
within 24 hours was
lower in group with
ketamine vs. control
Reduced postoperative
pain scores
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Placebocontrolled,
randomized,
doubleblinded study
South Egypt
Cancer
Institute

Interventional,
randomized,
clinical trial
Mayo Clinic
Florida

Mohamed
et al.
(2018)

Bojhaxi
(2019)

Independent:
Local wound
infiltration with
ketamine and
bupivacaine
(group K),
dexmedetomidine
and bupivacaine
(group D), or
control
(bupivacaine
only) after skin
closure and
before extubation
Dependent: total
dose IV PCA
morphine, first
request analgesia,
VAS score

Independent:
lidocaine
infusion from
induction through
time that patient
meets discharge
criteria from
recovery, placebo
Dependent: pain
in postop period,
opioid
consumption

90 patients
undergoing total
abdominal
hysterectomy
with low midline
vertical incision
ASA I-II
Age 18-80
Weight 50-85 kg

48 patients
undergoing
elective open or
laparoscopic total
pancreatectomies
ASA I-III
Age 18-80
BMI <40

Chi-square test
Kolmogorov–
Smirnov
normality test
Kruskal–Wallis
Mann_Whitney
test
Analyzed using
SPSS version
17

Mann-Whitney

Morphine
consumption,
time to first
analgesia
request,
Presence and
severity of pain
and rest and on
coughing (using
VAS score—
VAS-R and
VAS-M)

Pain in
postoperative
period
measured using
numerical
rating scale
(NRS)
Total opioid
consumption in
PACU
converted to
morphine
equivalents in
mg.

Strengths:
Infiltration of
wounds with
local anesthetics
can not only
provide analgesia
but may also
reduce the upregulation of
peripheral
nociceptors that
manifest as
increased
sensitivity to
pain, and could
therefore reduce
postoperative
stress response
Limitations:
single dose,
postoperative
infiltration, lack
of measurement
of serum levels of
ketamine and
dexmedetomidine
Strengths:
Utilizing
lidocaine drip to
reduce
postoperative
opioid
consumption
could feasibly be
implemented in
wide range of
procedures.
Limitations: Only
evaluated
effectiveness in
pancreatectomies,
not tested in
patients with
BMI >40.

PCA morphine
consumption: less in
group K and group D
than group C
Time to first request
analgesia: prolonged
in group K and group
D
Mean VAS-R score:
reduced in group K
compared to group C
in first 24 hours;
reduced in group D
compared to group C
in first 8 hours

Pain in postoperative
period was less in the
group receiving
lidocaine infusion
(P= 0.1459)
Total opioid
consumption in mg
was less in group
receiving lidocaine
infusion (P = 0.2050)

Level I
Grade B

Level I
Grade B

Local wound
infiltration with
ketamine or
dexmedetomidine
(added to
bupivacaine, vs
bupivacaine alone)
had an opioidsparing effect and
delayed first request
of rescue analgesia
in patients
undergoing total
abdominal
hysterectomy.

Lidocaine infusion
had an opioid
sparing effect and
decreased reported
postoperative pain
in patients
undergoing
pancreatectomy.
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Quasi
experimental
design
(historical
control
group)
MD
Anderson

Doubleblind RCT
Shahid
Sadoughi
Hospital in
Yazd, Iran

Meyer et
al.
(2018)

Jarahzadeh
et al.
(2016)

Independent:
ERAS protocol
Dependent:
median opioid
consumption,
pain scores

Independent:
intravenous
magnesium
sulfate infusion
Dependent:
narcotic
consumption 1,
2, 6, and 12
hours after
surgery, pain
score

533 patients in
cohort, 74
patients in
historical control
Age 18-85
Undergoing open
abdominal
surgery for
gynecologic
indications

60 patients in
Age 35-65
Undergoing
abdominal
hysterectomy
ASA I-II
Mean narcotic
consumption,
VAS pain score

Pain in POD 0-3
using numerical
rating scale
Opioid
consumption

VAS score, ttest, Chisquare test

Fisher exact
test
Wilcoxon
rank-sum test

Strengths: high
level of
compliant with
ERAS pathway,
additional
positive
outcomes
associated with
ERAS protocol
outside of
opioid reduction
Limitations:
historical
control group

Strengths:
Magnesium
decreases
irritability of
CNS and can
cause uterus to
relax.
Limitations:
small sample
size

No difference in pain
scores reported,
however,
intraoperative and
postoperative opioid
use was lower in ERAS
group.
Median intraoperative
opioid dose was
reduced 39% in ERAS
group
Postoperative opioid
dose was reduced 83%,
80%, 71%, and 50% on
POD 0, 1, 2, and 3,
respectively
Mean pain scores at all
time-points were lower
in study group than
placebo group.
Means of narcotic
consumption were
higher in placebo for all
measured time-points

Pain scores and mean
of narcotic
consumption in
measured time points
were lower in the
patients who
received magnesium
sulfate than in the
placebo group.

An ERAS protocol
can reduce opioid
intake in patients
following open
abdominal surgery
for gynecologic
conditions.

Level I
Grade B

Level II
Grade B
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Appendix D: Broward IRB Exemption Letter

Broward Health Medical Center
Broward Health Coral Springs
Broward Health Imperial Point
Broward Health North

Institutional Review Board - Human Research Protections

Salah Foundation Children’s Hospital
Broward Health Weston
Community Health Services
Broward Health Physician Group

DATE: 05/26/2021
TO: Rachel Kaplan, BSN
FROM: Broward Health Institutional Review Board
RECORD NUMBER: 2021-050
STUDY TITLE: Preoperative and Intraoperative Opioid-Sparing Analgesic Techniques to Reduce Post-Operative
Opioid Consumption in Patients Undergoing Open, Non-emergent Abdominal Surgeries: An Educational Module
RE: NOT HUMAN SUBJECT RESEARCH DETERMINATION
Dear Rachel Kaplan, BSN:
This is to advise you that your project, “Preoperative and Intraoperative Opioid-Sparing Analgesic Techniques to
Reduce Post-Operative Opioid Consumption in Patients Undergoing Open, Non-emergent Abdominal Surgeries: An
Educational Module ” was reviewed on behalf of the Broward Health Institutional Review Board and was declared
“not research involving human subjects” based on the definitions provided in the U.S. Department of Health and
Human Services Code of Federal Regulations found at 45 CFR 46.102.
Please note, this determination does not absolve the Principal Investigator from complying with other federal, state,
or local laws or institutional policies and procedures that may be applicable in the conduct of this project.
This determination applies to your project in the form and content as submitted to the IRB for review. Any variations
or modifications to this project involving the participation of human subjects must be approved by the IRB prior to
implementing such changes. Please maintain a copy of this determination for your records.
Thank you for submitting your project to the IRB for consideration.
The Broward Health Institutional Review Board – FWA00001248 operates in accordance with the Office of Human
Research Protections and U.S. Food and Drug Administration (FDA) regulations. The Broward Health Institutional
Review Board complies with the ICH guidelines on Good Clinical Practice (GCP) where they are compatible with the
FDA and HHS regulations.
This letter has been electronically signed in accordance with all applicable regulations, and a copy is retained
within Broward Health IRB’s records.

1600 S Andrews Avenue, Fort Lauderdale, FL 33316 , T - 954.355.4941 or 4358, F - 954.355.4930, http://www.browardhealth.org/pages/irb
IRB version dated 10.16.20
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Appendix F: QI Project Survey

Pre-test and Post-test Questionnaire:
Preoperative and Intraoperative Opioid-Sparing Analgesic Techniques to Reduce Postoperative
Opioid Consumption in Patients Undergoing Open, Non-emergent Abdominal Surgeries: An
Educational Module

INTRODUCTION

The primary aim of this QI project is to enhance the knowledge of CRNAs pertaining to
preoperative and intraoperative opioid-sparing analgesic techniques that reduce postoperative
opioid consumption in patients undergoing open, non-emergent abdominal surgeries.

Please answer the question below to the best of your ability. The questions are either in multiple
choice or true/false format and are meant to measure knowledge and perceptions on non-opioid
analgesic techniques in the surgery of interest.

DEMOGRAPHICS

1. Gender: Male Female Prefer not to answer
2. Age:

<18

18-29

3. Ethnicity: Caucasian

30-49

African American

American Indian or Alaskan Native
Islander

>50

Other

Asian
Native Hawaiian or Pacific
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4. Position/Title: _________________________________
5. Level of Education: Associates
Doctorate

Bachelors
Other

Masters

Prefer not to answer

QUESTIONNAIRE

1. One of the most commonly cited fears of patients scheduled for surgery is the fear of:
a. Dental trauma
b. Awareness
c. Infection
d. Postoperative pain

2. The U.S. Government declared the opioid epidemic a public health emergency in:
a. 2012
b. 2015
c. 2017
d. 2019

3. Ineffectively controlled postoperative pain is related to all of the following except:
a. increased morbidity
b. decreased functional capabilities
c. extended periods of narcotic use
d. increased nausea and vomiting
e. higher medical services costs

4. Over ____% of surgical patients receive opioids after low-risk surgery.
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a. 60
b. 70
c. 80
d. 90

5. Treatment of chronic pain that evolves from acute pain is estimated to cost up to _____
per patient.
a. $250,000
b. $500,000
c. $750,000
d. $1,000,000

6. The costly economic impact of opioid-related adverse effects stems from (select all that
apply):
a. Increased length of hospital stay
b. Incontinence
c. Functional impairment
d. Morbidity
e. Neuropathic pain

7. Withholding opioids and other analgesics from surgical patients intraoperatively:
a. Is an effective method of reducing opioid consumption
b. Leads to lower patient reported pain scores postoperatively
c. Could lead to an increase in chronic pain evolving from poorly managed acute
pain
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8. Which of the following is a secondary outcome of reduced postoperative opioid
consumption (select all that apply)?
a. Decreased time to first meal
b. Increased time to first ambulation
c. Increased time to foley removal
d. Decreased nausea and vomiting
e. Increased patient satisfaction

9. The incidence of opioid abuse postoperatively varies based on: (select all that apply)
a. Age
b. Genetics
c. Weight
d. Medical history
e. Surgical procedure

10. Which of the following statements is true?
a. Pregabalin is most effective when administered postoperatively.
b. IV magnesium reduces opioid consumption and prolongs neuromuscular
blockade but does not improve patient reported pain scores.
c. Single dose rectus sheath block is equally effective as repeated dose rectus sheath
block
d. Intravenous lidocaine infusion reduced mean opioid consumption

11. How comfortable are you with recommending/ordering one of the studied preoperative
non-opioid interventions for a patient undergoing open non-emergent abdominal surgery?
a. Extremely comfortable
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b. Somewhat comfortable
c. Neither comfortable nor uncomfortable
b. Somewhat uncomfortable
c. Extremely uncomfortable

12. How likely are you to recommend one of the studied intraoperative non-opioid interventions
in order to reduce opioid usage postoperatively?
a. Very likely
b. Somewhat likely
c. Neither likely or unlikely
d. Somewhat unlikely
e. Very unlikely
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